drugset / Trial / NCT03666546

Blood Glucose Response After Oral Intake of Lactulose in Mildly Constipated Patients With Diabetes Mellitus Type 2

NCT03666546

Phase 4 Completed 24 enrolled Fresenius Kabi
RandomizedCrossoverDouble-blindBasic science

Summary

The objective of the study is to investigate whether lactulose, given orally as powder or liquid, increases blood glucose levels in patients with diabetes mellitus type 2. The dose of lactulose given in the study is normally used for treatment of constipation.

Timeline

Start
2018-11-26
Primary completion
2019-03-05
Completion
2019-03-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Glucose Unknown 33 g Oral
Subject Lactulose Other / unclassified 20 g Oral
Subject Lactulose Other / unclassified 30 g Oral